Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s share price reached a new 52-week low during trading on Thursday. The company traded as low as C$0.10 and last traded at C$0.10, with a volume of 26,520 shares traded. The stock had previously closed at C$0.11.
Nanalysis Scientific Stock Down 4.5%
The firm has a market cap of C$14.64 million, a P/E ratio of -3.50 and a beta of -0.58. The firm’s fifty day moving average is C$0.12 and its 200 day moving average is C$0.13. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.10 and a current ratio of 1.42.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Read More
- Five stocks we like better than Nanalysis Scientific
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
